Nate Tower

Nate Tower currently serves as an Analyst at Samsara BioCapital, a venture capital firm dedicated to investments in the biotechnology and life sciences sectors. In this capacity, he is responsible for evaluating emerging bio-related opportunities, conducting technical due diligence on prospective portfolio companies, and analyzing broader market trends within the biopharmaceutical industry. Operating within a highly specialized investment landscape, Tower assists the firm's senior partners in identifying promising therapeutic platforms and early-stage medical innovations that require institutional capital to scale clinical development. His analytical work directly supports the deployment of venture funding into startups focused on novel drug discovery, advanced genetic medicines, and other critical healthcare technologies. Tower's current professional focus remains centered on leveraging his biotechnology expertise to drive strategic venture capital investments and support the growth of early-stage life science and biopharmaceutical enterprises.